Literature DB >> 6639837

Prediction of maintenance oral theophylline dosage using single oral doses in patients with obstructive airways disease.

D R Taylor, C D Kinney, D G McDevitt.   

Abstract

This study was designed to test whether single oral doses of theophylline, rather than the specified single intravenous infusions, could be used with a nomogram designed to predict the maintenance oral dose necessary to establish plasma theophylline concentrations of 10 micrograms ml (Koup et al., 1979) in patients with obstructive airways disease. A test dose of theophylline (5 mg kg) was administered on two separate occasions as an oral elixir and as an intravenous infusion. Exactly 6 h after each test dose, plasma theophylline concentration was measured, and the result used to predict daily maintenance dose requirements. During subsequent oral administration, a sustained-release preparation was given in equally divided 12-hourly doses, and 'steady-state' concentrations were measured at trough. Nineteen patients completed the study, and on doses ranging from 4.2 to 21.1 mg kg-1 day-1, trough concentrations of 5.4 to 15.8 micrograms ml (mean 10.0 +/- 0.7 micrograms ml) were achieved. No significant differences were noted between the dose predictions made following either the oral or the intravenous test doses, and the predictive accuracy using the oral route was not compromised. This would suggest that the test dose of theophylline may be administered orally, instead of intravenously, with this nomogram without reducing its efficiency.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6639837      PMCID: PMC1428057          DOI: 10.1111/j.1365-2125.1983.tb02208.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  15 in total

1.  Measurement of theophylline in plasma by high performance liquid chromatography.

Authors:  J G Kelly; W J Leahey
Journal:  Br J Clin Pharmacol       Date:  1976-10       Impact factor: 4.335

2.  Clinical experience with theophylline. Relarionships between dosage, serum concentration, and toxicity.

Authors:  M H Jacobs; R M Senior; G Kessler
Journal:  JAMA       Date:  1976-05-03       Impact factor: 56.272

Review 3.  Clinical pharmacokinetics of theophylline.

Authors:  R I Ogilvie
Journal:  Clin Pharmacokinet       Date:  1978 Jul-Aug       Impact factor: 6.447

Review 4.  Monitoring serum theophylline levels.

Authors:  L Hendeles; M Weinberger; G Johnson
Journal:  Clin Pharmacokinet       Date:  1978 Jul-Aug       Impact factor: 6.447

5.  Rational intravenous doses of theophylline.

Authors:  P A Mitenko; R I Ogilvie
Journal:  N Engl J Med       Date:  1973-09-20       Impact factor: 91.245

6.  Pharmacologic effects of intravenously administered aminophylline in asthmatic children.

Authors:  R Maselli; G L Casal; E F Ellis
Journal:  J Pediatr       Date:  1970-05       Impact factor: 4.406

7.  Hypothesis for the individualisation of drug dosage.

Authors:  J R Koup; C M Sack; A L Smith; M Gibaldi
Journal:  Clin Pharmacokinet       Date:  1979 Nov-Dec       Impact factor: 6.447

8.  Controlled release theophylline.

Authors:  S Riegelman; J W Jenne
Journal:  Chest       Date:  1980-08       Impact factor: 9.410

9.  Prediction of optimum oral theophylline dose in patients with obstructive airways disease.

Authors:  D R Taylor; C D Kinney; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1983-06       Impact factor: 4.335

10.  Oral sustained-release aminophylline in medical inpatients: factors related to toxicity and plasma theophylline concentrations.

Authors:  L E Ramsay; A Mackay; M L Eppel; J S Oliver
Journal:  Br J Clin Pharmacol       Date:  1980-08       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.